Bibliographie

1- Avina-Zubieta J.A et coll. Risk of Cardiovascular Mortality in Patients With

Rheumatoid Arthritis : A Meta-Analysis of Observational Studies. Arthritis & Rheumatism (Arthritis Care & Research) Vol. 59, No. 12, 2008, pp 1690–1697

2- Société Française d'Athérosclérose - Le risque cardio-vasculaire

3- Conroy RM et coll. SCORE project group. Estimation of ten-year of fatal cardiovascular disease in Europe : The SCORE project. Eur Heart J 2003;24(11):987-1003.

4- Goodson NJ et coll. The cardiovascular manifestationsof rheumatic diseases. Curr Opin Rheumatol 2006;18:135–40.

5- Bartoloni E et coll. How early is the atherosclerotic risk in rheumatoid arthritis ? Autoimmun Rev 2010, 9 :701–707.

6- Gabriel SE, et coll. Survival in rheumatoid arthritis : a population-based analysis of trends over 40 years. Arthritis Rheum 2003, 48 :54–58

7- Peters MJ etcoll. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010 69 :325–331.

8- Toms TE et coll. Statin use in rheumatoid arthritis in relation to actual cardiovascular risk : evidence for substantial undertreatment of lipid-associated cardiovascular risk? Ann Rheum Dis (2010) 69 :683–688

9- HAS 2008 Polyarthrite rhumatoïde évolutive grave. Voir le PDF

10- Soubrier M et coll. Le rhumatologue doit-il prescrire des statines ? Revue du rhumatisme 77 (2010) 115–117

11- Soubrier M et coll. Indications for lowering LDL-c in rheumatoid arthritis : an unrecognized problem. J Rheumatol 2006;33:1766–9.